The use of atmospheric pressure ionization MS in biomarker detection is still in its infancy and extensive research and validation of methods would be required to ensure the development of robust, reproducible methods. In this editorial the use of API technology is discussed as it could truly revolutionize biomarker discovery and point-of-care measurements.
Browsing: Expert opinion
Much of the science and healthcare news during these dire times has been disheartening. But there’s been at least one encouraging development: new COVID-19 vaccines are on track to be the fastest ever to market. And that accelerated pace might become the new normal.
Proteomics-based tumor biomarker discovery has come a long way since the days of two-dimensional gels. A multi-biomarker panel could incorporate different classes of biomolecules so as to narrate the disease history in a holistic manner.
Discover the latest updates on the ongoing novel coronavirus outbreak in this ‘In the Zone’. Here, you can discover the latest news headlines and updates.
The demand for analyzing biomarkers in drug development has increased dramatically with the advancement of precision medicine. In this editorial Weiping Shao (Frontage) discusses the challenges and key advice for outsourcing biomarker research.
New study reports cost-effective, rapid and easy to perform RT-PCR-based method for the detection of SARS-CoV-2, the virus termed COVID-19.
In this editorial Amandine Dispas (University of Liege, Belgium) discusses the versatility of SFC and the ongoing role of mass spectrometry in the latest chromatographic workflows. Does chromatography need mass spectrometry? Find out here.
In this editorial Isabelle Kohler (Leiden University, The Netherlands) explores the future of chromatography in bioanalysis. Is chromatography still a necessity in the face of developments in other analytical technologies?
To get a better understanding of the bioanalytical applications of chromatography we interviewed Makoto Tsunoda (University of Tokyo, Japan). Makoto described his research developing analytical methods to quantify endogenous compounds in a range of complex matrices.
In this presentation, Steve Kleiboeker (Viracor Eurofins; MO, USA) discusses CMV diagnostic testing; in particular the CMV T-cell immunity panel, which can help physicians predict which patients are at risk and be prepared to work with the patients pre-emptively before they develop the disease.